SEC Form 4 · accession 0000899243-18-031479
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ralf Kuriyel
Officer — Senior VP, R&D
Period of report
Dec 18, 2018
Accepted (ET)
Dec 20, 2018 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 18, 2018 | S | 311 | $54.44 | D | 12,294 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of 311 shares in the open market valued at a price of $54.44 per share on December 18,2018 to cover tax liability resulting from the release of restricted stock units.